AXPAXLI is currently in Phase 3 clinical trials for wet age-related macular degeneration (wet AMD ... for the treatment of ...

AMD patients referred to SpaMedica are offered an assessment within 14 days of referral SpaMedica is making eye health ...

When it comes to screening for retinopathy of prematurity (ROP), age-related macular degeneration (AMD), and diabetic retinopathy ... outcome and reducing the need for corrective glasses post-surgery.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers ...

(WKBN) — The earlier you catch lung cancer, the better and the American Cancer Society has updated its cancer screening ...

Dexamethasone implants improve visual and anatomical outcomes better than brolucizumab in patients with both DME and hyperreflective intraretinal dots.

MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced financial and operational results for the third quarter ended September 30, ...